CY1109763T1 - Υλικα και μεθοδος για τη θεραπεια διαταραχων πηξης - Google Patents
Υλικα και μεθοδος για τη θεραπεια διαταραχων πηξηςInfo
- Publication number
- CY1109763T1 CY1109763T1 CY20101100096T CY101100096T CY1109763T1 CY 1109763 T1 CY1109763 T1 CY 1109763T1 CY 20101100096 T CY20101100096 T CY 20101100096T CY 101100096 T CY101100096 T CY 101100096T CY 1109763 T1 CY1109763 T1 CY 1109763T1
- Authority
- CY
- Cyprus
- Prior art keywords
- sub
- compounds
- salts
- treatment
- materials
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/42—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4
- C07D311/56—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4 without hydrogen atoms in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Compounds Of Unknown Constitution (AREA)
- Saccharide Compounds (AREA)
- Pyridine Compounds (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Η εν λόγω εφεύρεση παρέχει αντιπηκτικές ενώσεις του τύπου (I): και φαρμακευτικώς αποδεκτά άλατα αυτών, όπου τα R1, R3, n και Ar έχουν όπως ορίζονται στην παρούσα. Οι ενώσεις της εν λόγω εφεύρεσης μπορούν να χρησιμοποιηθούν για τη θεραπεία πληθυσμών που κινδυνεύουν ανακουφίζοντας με αυτόν τον τρόπο από τα συμπτώματα, βελτιώνοντας την ποιότητα ζωής, προλαμβάνοντας οξείες και μακροπρόθεσμες επιπλοκές, μειώνοντας τη θνησιμότητα και θεραπεύοντας συνοδευτικές διαταραχές. Η εφεύρεση περαιτέρω περιλαμβάνει φαρμακευτικές συνθέσεις που περιέχουν τις ενώσεις και άλατα της εφεύρεσης, καθώς και μεθόδους χρησιμοποίησης των ενώσεων, αλάτων, και συνθέσεων της εφεύρεσης.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US56112104P | 2004-04-08 | 2004-04-08 | |
US10/822,129 US7145020B2 (en) | 2001-04-24 | 2004-04-08 | Materials and methods for treating coagulation disorders |
EP05733799A EP1735296B1 (en) | 2004-04-08 | 2005-04-08 | Materials and methods for treating coagulation disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1109763T1 true CY1109763T1 (el) | 2014-09-10 |
Family
ID=34965219
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20101100096T CY1109763T1 (el) | 2004-04-08 | 2010-01-29 | Υλικα και μεθοδος για τη θεραπεια διαταραχων πηξης |
Country Status (18)
Country | Link |
---|---|
US (1) | US7285671B2 (el) |
EP (1) | EP1735296B1 (el) |
JP (1) | JP5036532B2 (el) |
KR (1) | KR101203124B1 (el) |
AT (1) | ATE451361T1 (el) |
AU (1) | AU2005233614C1 (el) |
BR (1) | BRPI0508392A (el) |
CA (1) | CA2559568C (el) |
CY (1) | CY1109763T1 (el) |
DE (1) | DE602005018181D1 (el) |
DK (1) | DK1735296T3 (el) |
ES (2) | ES2436298T3 (el) |
HK (2) | HK1105200A1 (el) |
IL (1) | IL178122A (el) |
NO (1) | NO338837B1 (el) |
PT (1) | PT1735296E (el) |
RU (1) | RU2495034C2 (el) |
WO (1) | WO2005100336A1 (el) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1383756B1 (en) * | 2001-04-24 | 2008-03-05 | ARYx Therapeutics | Coumarin derivatives to be used as anticoagulants |
EP2161261B1 (en) * | 2004-04-08 | 2013-08-28 | Armetheon, Inc. | Materials and methods for treating coagulation disorders |
HUE027865T2 (en) * | 2005-12-01 | 2016-11-28 | Auspex Pharmaceuticals Inc | Substituted phenyl ethylamines with serotonergic and / or norepinephrine activity |
CN101188435B (zh) * | 2007-01-08 | 2011-03-16 | 中兴通讯股份有限公司 | 一种比特交织装置与方法 |
MX2010010504A (es) | 2008-03-26 | 2010-12-15 | Daiichi Sankyo Co Ltd | Derivado de hidroxi-quinoxalin-carboxamida. |
US9549912B2 (en) | 2009-11-23 | 2017-01-24 | Armetheon, Inc. | Methods for treating atrial fibrillation |
US20110136779A1 (en) * | 2009-11-23 | 2011-06-09 | Milner Peter G | Methods for stroke reduction in atrial fibrillation patients |
AU2010327936B2 (en) * | 2009-12-11 | 2015-08-20 | Nono Inc. | Agents and methods for treating ischemic and other diseases |
BR112012019529A2 (pt) | 2010-02-12 | 2019-09-24 | N30 Pharmaceuticals Llc | inibidores de d-nitrosoglutationa redutase |
JP5639665B2 (ja) | 2010-02-12 | 2014-12-10 | エヌサーティー・ファーマシューティカルズ・インコーポレーテッド | S−ニトロソグルタチオンレダクターゼのクロモン阻害剤 |
US11013739B2 (en) | 2014-01-15 | 2021-05-25 | Southern Methodist University | Inhibitors of multidrug resistance transporter p-glycoprotein |
US9561227B2 (en) | 2014-01-15 | 2017-02-07 | Southern Methodist University | Inhibitors of multidrug resistance transporter P-glycoprotein |
US11234978B2 (en) | 2014-01-15 | 2022-02-01 | Southern Methodist University | Inhibitors of multidrug resistance transporter P-glycoprotein |
US10292982B2 (en) | 2014-01-15 | 2019-05-21 | Southern Methodist University | Inhibitors of multidrug resistance transporter P-glycoprotein |
CN114524791B (zh) * | 2022-01-26 | 2024-01-26 | 江苏慧聚药业股份有限公司 | 替卡法林的制备方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL108459A0 (en) | 1993-02-05 | 1994-04-12 | Opjohn Company | 4-Hydroxy-benzopyran-2-ones and 4-hydroxy-cycloalkyl [B] pyran-2-ones useful for treating infections due to hiv and other retroviruses |
US5510375A (en) | 1993-11-19 | 1996-04-23 | Warner-Lambert Company | Coumarin derivatives as protease inhibitors and antiviral agents |
GB9324517D0 (en) * | 1993-11-30 | 1994-01-19 | Octel Chem Ltd | Process for the preparation of substituted 4-hydroxycoumarins |
FR2749585B1 (fr) * | 1996-06-11 | 1998-08-14 | Hoechst Marion Roussel Inc | Nouveaux derives aromatiques substitues par un ribose, leur procede de preparation et leur application comme medicaments |
FR2807032B1 (fr) * | 2000-03-29 | 2003-04-18 | Warner Lambert Co | Modification de la chimioselectivite lors de l'oxydation de composes organiques azotes |
US7145020B2 (en) | 2001-04-24 | 2006-12-05 | Aryx Therapeutics | Materials and methods for treating coagulation disorders |
EP1383756B1 (en) * | 2001-04-24 | 2008-03-05 | ARYx Therapeutics | Coumarin derivatives to be used as anticoagulants |
WO2003031415A1 (en) * | 2001-10-10 | 2003-04-17 | Aryx Therapeutics | Mibefradil-based compounds as calcium channel blockers useful in the treatment of hypertension and angina |
US7179838B2 (en) * | 2002-07-30 | 2007-02-20 | New Century Pharmaceuticals, Inc. | Coumarin analog compounds for safer anticoagulant treatment |
-
2005
- 2005-04-08 JP JP2007507551A patent/JP5036532B2/ja active Active
- 2005-04-08 AT AT05733799T patent/ATE451361T1/de active
- 2005-04-08 EP EP05733799A patent/EP1735296B1/en active Active
- 2005-04-08 AU AU2005233614A patent/AU2005233614C1/en not_active Ceased
- 2005-04-08 DK DK05733799.0T patent/DK1735296T3/da active
- 2005-04-08 BR BRPI0508392-3A patent/BRPI0508392A/pt not_active Application Discontinuation
- 2005-04-08 ES ES09175606T patent/ES2436298T3/es active Active
- 2005-04-08 DE DE602005018181T patent/DE602005018181D1/de active Active
- 2005-04-08 WO PCT/US2005/012091 patent/WO2005100336A1/en active Application Filing
- 2005-04-08 PT PT05733799T patent/PT1735296E/pt unknown
- 2005-04-08 KR KR1020067022954A patent/KR101203124B1/ko active IP Right Grant
- 2005-04-08 CA CA2559568A patent/CA2559568C/en active Active
- 2005-04-08 ES ES05733799T patent/ES2340690T3/es active Active
-
2006
- 2006-08-28 US US11/467,813 patent/US7285671B2/en active Active
- 2006-09-14 IL IL178122A patent/IL178122A/en active IP Right Grant
- 2006-11-03 NO NO20065079A patent/NO338837B1/no unknown
-
2007
- 2007-09-27 HK HK07110493.4A patent/HK1105200A1/xx unknown
-
2008
- 2008-05-21 RU RU2008120295/04A patent/RU2495034C2/ru active
-
2010
- 2010-01-29 CY CY20101100096T patent/CY1109763T1/el unknown
- 2010-04-12 HK HK10103549.8A patent/HK1138265A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CA2559568C (en) | 2013-05-28 |
AU2005233614B2 (en) | 2011-11-24 |
ES2436298T3 (es) | 2013-12-30 |
BRPI0508392A (pt) | 2007-08-07 |
DK1735296T3 (da) | 2010-02-01 |
EP1735296A1 (en) | 2006-12-27 |
RU2008120295A (ru) | 2009-11-27 |
KR101203124B1 (ko) | 2012-11-20 |
JP5036532B2 (ja) | 2012-09-26 |
US20060287388A1 (en) | 2006-12-21 |
AU2005233614A1 (en) | 2005-10-27 |
ES2340690T3 (es) | 2010-06-08 |
IL178122A (en) | 2013-01-31 |
CA2559568A1 (en) | 2005-10-27 |
US7285671B2 (en) | 2007-10-23 |
AU2005233614C1 (en) | 2012-07-19 |
NO20065079L (no) | 2006-11-03 |
HK1105200A1 (en) | 2008-02-06 |
PT1735296E (pt) | 2010-02-09 |
EP1735296B1 (en) | 2009-12-09 |
KR20060133081A (ko) | 2006-12-22 |
DE602005018181D1 (de) | 2010-01-21 |
ATE451361T1 (de) | 2009-12-15 |
IL178122A0 (en) | 2006-12-31 |
JP2007532575A (ja) | 2007-11-15 |
NO338837B1 (no) | 2016-10-24 |
WO2005100336A1 (en) | 2005-10-27 |
RU2495034C2 (ru) | 2013-10-10 |
HK1138265A1 (en) | 2010-08-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1109763T1 (el) | Υλικα και μεθοδος για τη θεραπεια διαταραχων πηξης | |
EA200800006A1 (ru) | Триазолопиридины в качестве ингибиторов 11-бета-гидроксистероиддегидрогеназы типа i | |
NO20073140L (no) | Pyrrolopyraziner og pyralopyraziner som er nyttige som inhibitorer av proteinkinaser | |
BRPI0412999A (pt) | 2-aminotetralina substituìda para tratamento de depressão | |
EA201001455A1 (ru) | Пиридины и пиразины в качестве ингибиторов pi3k (фосфатидилинозиткиназы-3) | |
EA200501936A1 (ru) | Производные пиридо[2,1-a]изохинолина в качестве ингибиторов dpp-iv | |
BRPI0307351B8 (pt) | composto, composição farmacêutica, uso de um composto, e, processo para preparar um composto | |
NO20070514L (no) | Pyrrolotriazin kinase inhibitorer | |
SE0301886D0 (sv) | New use V | |
EA200700096A1 (ru) | Производные 2-карбамид-4-фенилтиазола, способ их получения и их применение в терапии | |
ATE384058T1 (de) | Thiazolderivate | |
EA201200669A1 (ru) | ПИРИДОПИРИМИДИНОНОВЫЕ ИНГИБИТОРЫ PI3Kα | |
SE0301882D0 (sv) | New use I | |
DE602005013822D1 (de) | Cycloalkylaminderivate | |
SE0301888D0 (sv) | New use VII | |
ECSP055844A (es) | Nuevos compuestos triciclicos | |
BR0309343A (pt) | Composto, composição farmacêutica, uso de um composto, e, método de tratamento ou profilaxia de doenças ou condições humanas | |
WO2007024843A3 (en) | Pyrimidinyl-pyrazole inhibitors of aurora kinases | |
GB0112348D0 (en) | Compounds | |
BR0316458A (pt) | Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, método para intensificar a cognição em um paciente saudável, e, uso de um composto | |
UY28098A1 (es) | Derivados de anilinopirazol útiles en el tratamiento de la diabetes | |
DE60306546D1 (de) | Entzündungshemmende 3-arylthio-3-thiazolylalkylamine | |
DE60232173D1 (de) | Verwendung von sulfonamid-derivaten bei der behandlung von adipositas oder zur verringerung der nahrungsaufnahme | |
EA200601249A1 (ru) | Пиперазины, пригодные для лечения боли | |
DK1532131T3 (da) | Motilid-forbindelser |